TVTX (Travere Therapeutics) Price-to-Operating-Cash-Flow : (As of Jul. 13, 2025)

Travere Therapeutics Price-to-Operating-Cash-Flow Chart

Travere Therapeutics Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Price-to-Operating-Cash-Flow		Get a 7-Day Free Trial					-	-	-	-	-

Travere Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Travere Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Travere Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Travere Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Travere Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Travere Therapeutics's Price-to-Operating-Cash-Flow falls into.

Travere Therapeutics Price-to-Operating-Cash-Flow Calculation

Travere Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Travere Therapeutics's Share Price of today is $16.47.
Travere Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.97.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Travere Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Travere Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Travere Therapeutics Business Description